blue cross blue shield glp-1 coverage 2026 CMS has announced important updates to Medicare of medications for 2027. Instead of transitioning to the BALANCE Model, Medicare coverage for GLP-1 medications used for weight management will continue through Coverage of Obesity Therapies Diet Type_Diabetic Friendly Months:3 Month

blue cross blue shield glp-1 coverage 2026 CMS has announced important updates to Medicare of medications for 2027. Instead of transitioning to the BALANCE Model, Medicare coverage for GLP-1 medications used for weight management will continue through Coverage of Obesity Therapies Diet Type_Diabetic Friendly Months:3 Month

Coverage of Obesity Therapies in State-Regulated Markets

Tirzepatide is unique because it targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a dual agonist

Diet Type_Diabetic Friendly

Months:3 Month

11 It was later determined that higher concentrations were necessary to produce the same effect in vivo